{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:18:49Z","timestamp":1793103529365,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008639","name":"Sir Edward &apos;Weary&apos; Dunlop Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008639","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.diabres.2020.108296","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:19:20Z","timestamp":1593724760000},"page":"108296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic"],"prefix":"10.1016","volume":"166","author":[{"given":"Lori J.","family":"Sacks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia T.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Neoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif I.","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2020.108296_b0005","unstructured":"World Health Organisation. WHO Director-General\u2019s remarks at the media briefing on 2019-nCoV on 11 February 2020; [cited 2020 March 21]. Available from: https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020."},{"key":"#cr-split#-10.1016\/j.diabres.2020.108296_b0010.1","unstructured":"2.World Health Organisation. Coronavirus Disease 2019 (COVID-19) Situational Report - 61"},{"key":"#cr-split#-10.1016\/j.diabres.2020.108296_b0010.2","unstructured":"[cited 2020 March 22]. Available from: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200321-sitrep-61-covid-19.pdf?sfvrsn=f201f85c_2."},{"issue":"10","key":"10.1016\/j.diabres.2020.108296_b0015","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/thx.2010.136317","article-title":"The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies","volume":"65","author":"Yende","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.diabres.2020.108296_b0020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1186\/s12879-019-4592-0","article-title":"Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity","volume":"19","author":"Schoen","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.diabres.2020.108296_b0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.diabres.2020.108296_b0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4081\/jphr.2016.733","article-title":"Prevalence of diabetes in the 2009 influenza A (H1N1) and the middle east respiratory syndrome coronavirus: a systematic review and meta-analysis","volume":"5","author":"Badawi","year":"2016","journal-title":"J Public Health Res"},{"issue":"2","key":"10.1016\/j.diabres.2020.108296_b0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","article-title":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","volume":"4","author":"Pearson-Stuttard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2020.108296_b0040","doi-asserted-by":"crossref","unstructured":"Abu-Ashour W, Twells L, Valcour J, Randell A, Donnan J, Howse P, et al. The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies. 2017;5(1):e000336.","DOI":"10.1136\/bmjdrc-2016-000336"},{"issue":"2","key":"10.1016\/j.diabres.2020.108296_b0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000345107","article-title":"Diabetes and infection: is there a link?\u2013A mini-review","volume":"59","author":"Knapp","year":"2013","journal-title":"Gerontology"},{"key":"#cr-split#-10.1016\/j.diabres.2020.108296_b0050.1","unstructured":"Communicable Diseases Network Australia (CDNA) Department of Health. Coronavirus Disease 2019 (COVID-19) - CDNA National Guidelines for Public Health Units"},{"key":"#cr-split#-10.1016\/j.diabres.2020.108296_b0050.2","unstructured":"2020. [cited 2020 March 20]. Available from: https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cdna-song-novel-coronavirus.htm."},{"key":"10.1016\/j.diabres.2020.108296_b0055","unstructured":"Report of the WHO-China Joint Mission on Coronavirus DIsease 2019 (COVID-2019). 2020 February 16\u201324; 2020."},{"issue":"13","key":"10.1016\/j.diabres.2020.108296_b0060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2020.108296_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.diabres.2020.108296_b0070","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis","author":"Guan","year":"2020","journal-title":"Eur Respir J"},{"issue":"10223","key":"10.1016\/j.diabres.2020.108296_b0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China Lancet"},{"issue":"10223","key":"10.1016\/j.diabres.2020.108296_b0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2020.108296_b0085","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2020.108296_b0090","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108296_b0095","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108296_b0100","doi-asserted-by":"crossref","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan","author":"Zhang","year":"2020","journal-title":"China Allergy"},{"key":"10.1016\/j.diabres.2020.108296_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.diabres.2020.108296_b0110","first-page":"1","article-title":"China cardiovascular diseases report 2018: an updated summary","volume":"17","author":"Ma","year":"2020","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.diabres.2020.108296_b0115","unstructured":"International Diabetes Federation. China; 2020 [cited 2020 May 14]. Available from: https:\/\/idf.org\/our-network\/regions-members\/western-pacific\/members\/101-china.html."},{"key":"10.1016\/j.diabres.2020.108296_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.05.001","article-title":"Patients with diabetes are at higher risk for severe illness from COVID-19","author":"Targher","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2020.108296_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2020.108296_b0130","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108296_b0135","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108296_b0140","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically Ill patients in the Seattle region \u2013 case series","author":"Bhatraju","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2020.108296_b0145","doi-asserted-by":"crossref","unstructured":"Service ENH. COVID-19 total announced deaths 18 May 2020; 2020.","DOI":"10.22233\/20412495.0120.18"},{"key":"10.1016\/j.diabres.2020.108296_b0150","unstructured":"Team C-NIRS. COVID-19, Australia: Epidemiology Report 10: Reporting week ending 23:59 AEST 5 April 2020. Health AGDo; 2020."},{"issue":"4","key":"10.1016\/j.diabres.2020.108296_b0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A review of coronavirus disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J Pediatr"},{"issue":"1","key":"10.1016\/j.diabres.2020.108296_b0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.diabres.2020.108296_b0165","series-title":"Features evaluation and treatment coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"key":"10.1016\/j.diabres.2020.108296_b0170","doi-asserted-by":"crossref","unstructured":"Chowdhury RM, C. D. Biophysical characterization of the SARS-CoV2 spike protein binding with the ACE2 receptor explains increased COVID-19 pathogenesis; 2020.","DOI":"10.1101\/2020.03.30.015891"},{"key":"10.1016\/j.diabres.2020.108296_b0175","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.diabres.2020.108296_b0180","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/Angiotensin 1\u20137 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res"},{"issue":"43","key":"10.1016\/j.diabres.2020.108296_b0185","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.diabres.2020.108296_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198144","article-title":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease","volume":"13","author":"Ramchand","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.diabres.2020.108296_b0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","article-title":"ACE2, angiotensin-(1\u20137), and Mas: the other side of the coin","volume":"465","author":"Bader","year":"2013","journal-title":"Pflugers Arch"},{"issue":"5","key":"10.1016\/j.diabres.2020.108296_b0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","article-title":"Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor","volume":"93","author":"Lew","year":"2008","journal-title":"Exp Physiol"},{"issue":"2","key":"10.1016\/j.diabres.2020.108296_b0205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","article-title":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications","volume":"30","author":"Soro-Paavonen","year":"2012","journal-title":"J Hypertens"},{"issue":"9200","key":"10.1016\/j.diabres.2020.108296_b0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.diabres.2020.108296_b0215","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.diabres.2020.108296_b0220","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2020.108296_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.diabres.2020.108296_b0230","doi-asserted-by":"crossref","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","article-title":"MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"10.1016\/j.diabres.2020.108296_b0235","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.diabres.2020.108296_b0240","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.diabres.2020.108296_b0245","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.diabres.2020.108296_b0250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.diabres.2020.108296_b0255","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"10.1016\/j.diabres.2020.108296_b0260","first-page":"1280","article-title":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling","volume":"19","author":"Walters","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.diabres.2020.108296_b0265","unstructured":"Society AD. Australian diabetes society communique for diabetes health professionals regarding COVID-19 pandemic; 2020."},{"issue":"20","key":"10.1016\/j.diabres.2020.108296_b0270","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131774","article-title":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection","volume":"4","author":"Kulcsar","year":"2019","journal-title":"JCI Insight"},{"issue":"5091","key":"10.1016\/j.diabres.2020.108296_b0275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.diabres.2020.108296_b0280","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2020.108296_b0285","article-title":"Type 2 diabetes and its impact on the immune system","author":"Berbudi","year":"2019","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.diabres.2020.108296_b0290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cca.2016.08.015","article-title":"Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications","volume":"462","author":"Meshkani","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.diabres.2020.108296_b0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V","article-title":"Impaired leucocyte functions in diabetic patients","volume":"14","author":"Delamaire","year":"1997","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.diabres.2020.108296_b0300","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1172\/JCI656","article-title":"Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion","volume":"101","author":"Morigi","year":"1998","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.diabres.2020.108296_b0305","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02581126","article-title":"The influence of increasing glucose concentrations on selected functions of polymorphonuclear neutrophils","volume":"25","author":"Wierusz-Wysocka","year":"1988","journal-title":"Acta Diabetol Lat"},{"issue":"6","key":"10.1016\/j.diabres.2020.108296_b0310","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/08820137809068727","article-title":"Influence of intermittent hyperglycemic glucose levels on the phagocytosis of microorganisms by human granulocytes in vitro","volume":"7","author":"Van Oss","year":"1978","journal-title":"Immunol Commun"},{"key":"10.1016\/j.diabres.2020.108296_b0315","doi-asserted-by":"crossref","DOI":"10.1080\/15476910802604564","article-title":"Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions","author":"Daoud","year":"2009","journal-title":"Immunotoxicology"},{"issue":"8","key":"10.1016\/j.diabres.2020.108296_b0320","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2337\/diabetes.38.8.1031","article-title":"Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro","volume":"38","author":"Nielson","year":"1989","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.diabres.2020.108296_b0325","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.febslet.2013.05.053","article-title":"High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation","volume":"587","author":"Joshi","year":"2013","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.diabres.2020.108296_b0330","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am J Med Sci"},{"issue":"10","key":"10.1016\/j.diabres.2020.108296_b0335","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.diabres.2020.108296_b0340","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/486403","article-title":"Stress hyperglycemia, insulin treatment, and innate immune cells","volume":"2014","author":"Xiu","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.diabres.2020.108296_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2020.108296_b0350","article-title":"The clinical characteristics and outcomes of diabetes mellitus and secondary hyperglycaemia patients with coronavirus disease 2019: a single-center, retrospective. observational study in Wuhan","author":"Zhang","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2020.108296_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108214","article-title":"Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients","volume":"164","author":"Wang","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108296_b0360","doi-asserted-by":"crossref","DOI":"10.1177\/1932296820924469","article-title":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States","author":"Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.diabres.2020.108296_b0365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12933-020-01035-2","article-title":"Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19","volume":"19","author":"Ren","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2020.108296_b0370","unstructured":"Fund IM. World economic outlook; 2020 (Chapter 1 The Great Lockdown)."},{"key":"10.1016\/j.diabres.2020.108296_b0375","unstructured":"Unemployment to hit 10 per cent, 1.4m Aussies out of work: Treasury [press release]. Shane Wright 2020 [cited 2020 April 24]. Available from: https:\/\/www.smh.com.au\/politics\/federal\/unemployment-to-hit-10-per-cent-1-4m-aussies-out-of-work-treasury-20200413-p54jd6.html."},{"key":"10.1016\/j.diabres.2020.108296_b0380","unstructured":"Australian Government. Economic response to the coronavirus; 2020 [cited 2020 April 28]. Available from: https:\/\/treasury.gov.au\/coronavirus."},{"key":"10.1016\/j.diabres.2020.108296_b0385","unstructured":"Australian Bureau of Agricultural and Resource Economics and Sciences. Analysis of Australia\u2019s food security and the COVID-19 pandemic. Canberra; 2020 [cited 2020 April 28]. Available from: https:\/\/www.agriculture.gov.au\/abares\/publications\/insights\/australian-food-security-and-COVID-19-empty-supermarket-shelves-reflect-an-unexpected-surge-in-demand-as-consumers-stockpile-food-taking-supply-chains-by-surprise."},{"key":"10.1016\/j.diabres.2020.108296_b0390","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1186\/1471-2458-13-828","article-title":"Associations between psychological stress, eating, physical activity, sedentary behaviours and body weight among women: a longitudinal study","volume":"13","author":"Mouchacca","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.diabres.2020.108296_b0395","unstructured":"Monash University. Coronavirus: Recognising disenfranchised grief amid COVID-19 [press release]; 2020 [cited 2020 April 28]. Available from: https:\/\/treasury.gov.au\/coronavirus."},{"key":"10.1016\/j.diabres.2020.108296_b0400","unstructured":"Beyond Blue. New dedicated service to support Australia\u2019s mental health through COVID-19 [press release]; 2020 [cited 2020 April 28]. Available from: https:\/\/www.beyondblue.org.au\/media\/media-releases\/media-releases\/new-dedicated-service-to-support-australia-s-mental-health-through-covid-19."},{"issue":"7","key":"10.1016\/j.diabres.2020.108296_b0405","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/diacare.23.7.934","article-title":"Depression and poor glycemic control: a meta-analytic review of the literature","volume":"23","author":"Lustman","year":"2000","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2020.108296_b0410","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2190\/KLGD-4H8D-4RYL-TWQ8","article-title":"Anxiety and poor glycemic control: a meta-analytic review of the literature","volume":"32","author":"Anderson","year":"2002","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.diabres.2020.108296_b0415","unstructured":"Australian Government Department of Health. COVID-19 Temporary MBS Telehealth Services; 2020 [cited 2020 April 14]. Available from: http:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/Factsheet-TempBB."},{"key":"10.1016\/j.diabres.2020.108296_b0420","unstructured":"Australian Government Department of Health. Self-isolation (self-quarantine) for coronavirus (COVID-19); 2020."},{"key":"10.1016\/j.diabres.2020.108296_b0425","unstructured":"Mcdonald K. COVID-19 resources: telehealth. Pulse+IT Magazine; 2020 21 April 2020. Available from: https:\/\/www.pulseitmagazine.com.au\/australian-ehealth\/5460-covid-19-resources-telehealth."},{"key":"10.1016\/j.diabres.2020.108296_b0430","first-page":"CD002098","article-title":"Interactive telemedicine: effects on professional practice and health care outcomes","volume":"9","author":"Flodgren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.diabres.2020.108296_b0435","first-page":"42","article-title":"Telemedicine in complex diabetes management","volume":"18","author":"McDonnell","year":"2018","journal-title":"Curr DiabRep"},{"issue":"8","key":"10.1016\/j.diabres.2020.108296_b0440","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016242","article-title":"Telehealth and patient satisfaction: a systematic review and narrative analysis","volume":"7","author":"Kruse","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.diabres.2020.108296_b0445","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1357633X16674087","article-title":"Evaluating barriers to adopting telemedicine worldwide: a systematic review","volume":"24","author":"Scott Kruse","year":"2018","journal-title":"J Telemed Telecare"},{"key":"10.1016\/j.diabres.2020.108296_b0450","unstructured":"Department of Health. Ensuring continued access to medicines during the COVID-19 pandemic [press release]; 2020 [cited 2020 April 16]. Available from: https:\/\/www.health.gov.au\/ministers\/the-hon-greg-hunt-mp\/media\/ensuring-continued-access-to-medicines-during-the-covid-19-pandemic."},{"key":"10.1016\/j.diabres.2020.108296_b0455","unstructured":"58,000 type 1 diabetes to have free access to new glucose monitoring device [press release]; 2020 [cited 2020 April 16]. Available from: https:\/\/www.health.gov.au\/ministers\/the-hon-greg-hunt-mp\/media\/58000-type-1-diabetics-to-have-free-access-to-new-glucose-monitoring-device."},{"key":"10.1016\/j.diabres.2020.108296_b0460","article-title":"Distal technology interventions in people with diabetes: an umbrella review of multiple health outcomes","author":"Chakranon","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2020.108296_b0465","unstructured":"O\u2019Brien J. Coronavirus (COVID-19) in Australia; 2020."},{"key":"10.1016\/j.diabres.2020.108296_b0470","unstructured":"Department of Health. Limits on public gatherings for coronavirus (COVID-19); 2020 [cited 2020 April 27]. Available from: https:\/\/www.health.gov.au\/news\/health-alerts\/novel-coronavirus-2019-ncov-health-alert\/how-to-protect-yourself-and-others-from-coronavirus-covid-19\/limits-on-public-gatherings-for-coronavirus-covid-19."},{"issue":"8","key":"10.1016\/j.diabres.2020.108296_b0475","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2019-00139","article-title":"SGLT2 inhibitors increase the risk of diabetic ketoacidosis developing in the community and during hospital admission","volume":"104","author":"Hamblin","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720305489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720305489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:12:44Z","timestamp":1759173164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822720305489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":97,"alternative-id":["S0168822720305489"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108296","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108296"}}